You are here

  • Home
  • Archive
  • Volume 9, Issue 12
  • An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade

 

Online download statistics by month:

Online download statistics by month: December 2021 to March 2024

AbstractFullPdf
Dec 2021462480165
Jan 2022458473256
Feb 2022155158102
Mar 2022106108126
Apr 20227679122
May 20229095128
Jun 2022113113165
Jul 2022127130162
Aug 2022148156180
Sep 2022129129128
Oct 202218218295
Nov 202216016472
Dec 2022656540
Jan 2023565740
Feb 202311311871
Mar 2023969767
Apr 2023575738
May 2023757554
Jun 2023606246
Jul 2023434330
Aug 2023585851
Sep 2023696934
Oct 2023484825
Nov 2023858547
Dec 202315015038
Jan 2024757948
Feb 2024808043
Mar 20249799129
Total343335092502